Salbutamol

Страна: Армения

Язык: английский

Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активный ингредиент:

salbutamol (salbutamol sulfate)

Доступна с:

Glaxo Wellcome Production

ИНН (Международная Имя):

salbutamol (salbutamol sulfate)

дозировка:

100mcg/dose

Фармацевтическая форма:

aerosol for inhalation, dosed

Тип рецепта:

Prescription

Характеристики продукта

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Salbutamol
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Salbutamol is a pressurised metered-dose inhaler delivering 100
micrograms of salbutamol
(as Salbutamol Sulfate) per actuation. Salbutamol contains a new
propellant (HFA 134a) and
does not contain any chlorofluorocarbons.
3.
PHARMACEUTICAL FORM
Dosed aerosol for inhalation
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Salbutamol is indicated in adults, adolescents and children aged 4 to
11 years. For babies and
children under 4 years of age, see sections 4.2 and 5.1.
Salbutamol provides short-acting (4 to 6 hour) bronchodilation with
fast onset (within 5 minutes) in
reversible airways obstruction.
It is particularly suitable for the relief and prevention of asthma
symptoms. It should be used to
relieve symptoms when they occur, and to prevent them in those
circumstances recognised by the
patient to precipitate an asthma attack (e.g. before exercise or
unavoidable allergen exposure).
Salbumatol is particularly valuable as relief medication in mild,
moderate or severe asthma, provided
that reliance on it does not delay the introduction and use of regular
inhaled corticosteroid therapy.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Salbutamol is for oral inhalation use only. Salbutamol may be used
with a Volumatic™ spacer device
by patients who find it difficult to synchronise aerosol actuation
with inspiration of breath.
Adults (including the elderly):
For the relief of acute asthma symptoms including bronchospasm, one
inhalation (100 micrograms)
may be administered as a single minimum starting dose. This may be
increased to two inhalations if
necessary. To prevent allergen- or exercise-induced symptoms, two
inhalations should be taken 10-15
minutes before challenge.
For chronic therapy, two inhalations up to four times a day.
Paediatric Population
_Relief of acute bronchospasm _
The usual dosage for children under the age of 12 years: one
inhalation (100 micrograms). The dose
may be increa